OrthoLogic President/COO George Oram puts new face on management of embattled firm.
This article was originally published in The Gray Sheet
Executive SummaryORTHOLOGIC PRESIDENT/COO GEORGE ORAM PUTS NEW FACE ON MANAGEMENT of the bone growth stimulator firm as it prepares to respond to two shareholder lawsuits and an inquiry by the National Association of Securities Dealers. An OrthoLogic board member since 1992 and president and CEO of pharmaceutical firm Fibromed, Oram, 48, will take over "day-to-day" responsibility of OrthoLogic from company founder Allan Weinstein. Weinstein, who will retain the titles of chairman and CEO, is a co-defendant in the shareholder suits, and his recent trades of OrthoLogic stock are likely to be reviewed in the NASD inquiry.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.